This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Joe Valli, a serial entrepreneur and founder of Quiet Light Brokerage, one of the leading online-focused M&A advisory firms in the world, has helped facilitate over a half billion in exits. Ron Concept 1: Maximize Business Value When Exiting When it comes to exiting a business, maximizing value is of paramount importance.
On the surface, things looked rough: the Dow Jones, S&P 500, and the NASDAQ all finished the year with significant losses, with tech stocks hit particularly hard. After the unprecedented market highs of 2020 into 2021, it’s natural for founders in this environment to wonder if they’ve missed the boat. 4Q22’s multiple of 5.6x
The following report examines the health and outlook for insurance M&A deals in 2024. We base this research on several key findings in our proprietary SF database, which observes and records data from the top ~400 insurance M&A buyers. Agency vs. Company: Which Is The Better Insurance M&A Deal?
M&A transactions for insurance companies are part of a robust but complicated market that requires ingesting a great deal of data in order to fully understand. While insurance M&A did see slight dips in deal volume and average value (Fig.2)
In it, we provide readers with a quick and simple overview of the current insurance brokerage M&A market , after which we discuss several macroeconomic and industry-specific factors that could drastically affect transactions in the next six months. The market is already highly competitive, but it’s also limited to what buyers can afford.
I was there through 2015, then Bank of America, before I joined Conversant Capital in early 2021. When Mike called me about the opportunity to join Conversant, he emphasised the firm’s long-term, buy-and-hold strategy, akin to private equity. There’s been a reopening in capital markets. It’s been busy.
The insurance M&A market in 2024 is significantly more complex now than it was 20 years ago. However, this report seeks to make sense of these qualities as a whole to provide an overview of the 2024 insurance M&A market. The table of contents below offers quick links for readers seeking specific information in later sections.
Introduction and Market Update With proxy season underway, FTI Consulting’s Activism and M&A Solutions team welcomes readers to our quarterly Activism Vulnerability Report, which highlights the findings of our Activism Vulnerability Screener for 4Q22 and discusses other notable themes and trends in the world of shareholder activism.
This was despite a generally favorable market that pushed the S&P 500 up 3.6% However, the sector still lagged both the S&P 500 and NASDAQ by a wide margin over the past year. The S&P 500 is up 26.3% and the NASDAQ up 4.0%. over this time frame, while the NASDAQ gained 29.4%. revenue and 24.9x
Reed and Michael P. Chief legal officer Joshua S. Goldman Sachs Bank USA and JPMorgan Chase Bank NA are providing Nasdaq with bridge financing for the deal. Lam and Veblen counseled Nasdaq on its $2.75 billion purchase of Verafin Inc. Lam has done several other deals for Nasdaq, including its purchases of Solovis Inc. billion in 2016.
Ron rn rn rn About The Guest(s): Juan Braschi is the CEO of Boopos, a company that helps talented buyers acquire businesses and provides flexible financing for buying e-commerce and software-as-a-service (SaaS) businesses. Juan has a background in finance and technology, and he has experience in investment banking and private equity.
DEN) turned to Stephen M. Cox, Andrew P. Denbury chief administrative officer and general counsel James S. Denbury joined The Deal’s Watch List and Crosshairs of possible activist targets in June 2021, given its potential appeal to supermajors such as Exxon or Chevron Corp. Also in 2021, ESG activist Engine No.
She joined Ninety One in 2021 from Royal London Asset Management where she had been head of dealing for three years. Markets are constantly challenging and that’s the key aspect to our role.” The London-based trading team at Ninety One has a very particular set of skills. Markets have been tricky.
The burden in 2021 will continue to fall on the marketplace, as we struggle toward ‘generally accepted ESG reporting principles.’ Today’s topic broadly covers the current shareholder landscape. Here are some connections on things that are interesting to me: John Coates was named Acting Director of the SEC’s Division of Corporate Finance.
No matter the economic climate, you can always bet on sports fans to show up for their favorite teams. This partially explains why sports investment banking has become a hot field, with JP Morgan and Goldman Sachs launching their own sports coverage groups. Sir Jim Ratcliffe and Manchester United or Mark Cuban and the Mavericks).
As vaccine distributions bring us ever closer to putting COVID-19 firmly in our rearview mirror, the past year will become remembered as a period of cancelled plans, mask mandates, and bizarre events unlike anything most of us had seen in modern history. As we have been reminded throughout history, growth isn’t perpetual.
2023’s much-discussed downturn in mergers & acquisitions – with global M&A volume and value down 6% and 17%, respectively, from 2022 – was largely driven by the slowdown in the tech sector, with global tech M&A volumes down 51% year over year, while other sectors saw marked increases. [1] billion leading the pack.
General trends in life sciences M&A. Although the COVID-19 pandemic that defined 2020 continued to shape much of the life sciences industry in 2021, the way that it did was markedly different. 2] Examples of this strategy coming to bear in 2021 included Thermo Fisher Scientific’s acquisition of PPD for $17.4 driven assets.
S&P Global and CME Group today have signed a definitive agreement to sell post-trade solutions provider OSTTRA to investment funds managed by KKR. billion and is set to be divided evenly between S&P Global and CME Group as each hold a 50% interest. The post CME and S&P offload OSTTRA in $3.1
43% of 2024 activist campaigns were M&A focused, in line with the three-year average. 2024 was a prolific year for activists, with 243 campaigns launched globally the highest number since 2018. US activity was up modestly, and a busy year in Asia offset a quieter year in Europe.
This significantly underperformed the returns of both the S&P 500 (up 2.1%) and the NASDAQ (up 6.2%) over the corresponding time frame.When viewed over the past 12-months, the TBSI is down 3.1%. The S&P 500 is up 23.3% Once again, this compares unfavorably to the broader indices. revenue and 10.5x revenue and 11.6x
David Dart: Well, well, there’s a couple of really important elements that we’re driving here at Caliber Number one, our technician apprentice program. So that’s a really critically important talent development function that we have. Cole Strandberg: Let’s do both. David Dart: Yeah, I think it was pretty.
Government funded programs include Medicare, Medicaid, Children’s Health Insurance Program, and the Veterans Health Administration. Over the last year, the biotech industry has seen considerable growth compared to the S&P 500. The healthcare sector in the United States is a large driver of economic output.
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content